VNDA insider filings

Vanda Pharmaceuticals Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-05. Screen VNDA transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Duncan Charles Cliff — Director13 legs · 10,000 sh · $38,094——

Recent insider filings — Vanda Pharmaceuticals Inc.

FiledFormInsiderReported transactionsSource
2026-11-054Duncan Charles Cliff — DirectorPurchase (P): 750 @ $3.80 · Purchase (P): 3,447 @ $3.82 · Purchase (P): 5,803 @ $3.80EDGAR
2026-06-084McGuire Daniel Patrick — SVP, GC and SecretaryGrant/award (A): 80,000 @ $0EDGAR
2026-06-084Chrousos Phaedra — DirectorGrant/award (A): 41,600 @ $0EDGAR
2026-06-084Duncan Charles Cliff — DirectorGrant/award (A): 41,600 @ $0EDGAR
2026-06-084Ward Anne Sempowski — DirectorGrant/award (A): 41,600 @ $0EDGAR
2026-06-084Honore Tage — DirectorGrant/award (A): 41,600 @ $0EDGAR
2026-06-084Mitchell Stephen Ray — DirectorGrant/award (A): 41,600 @ $0EDGAR
2026-06-084DUGAN RICHARD W — DirectorGrant/award (A): 41,600 @ $0EDGAR
2026-05-204Mitchell Stephen Ray — DirectorGift (G): 25,836 @ $0EDGAR
2026-04-244Duncan Charles Cliff — DirectorGrant/award (A): 57,101 @ $0EDGAR
2026-03-044Moran Kevin Patrick — SVP, CFO & TreasurerSale (S): 42,442 @ $8.27EDGAR
2026-03-044Wijkstrom Joakim — SVP, Chief Marketing OfficerSale (S): 30,800 @ $8.27EDGAR
2026-03-044Williams Timothy — SVP & General CounselSale (S): 42,434 @ $8.27EDGAR
2026-03-044Birznieks Gunther — SVP, Business DevelopmentSale (S): 42,431 @ $8.27EDGAR
2026-03-044Polymeropoulos Mihael Hristos — President and CEO, DirectorSale (S): 156,235 @ $8.17EDGAR
2026-02-244Honore Tage — DirectorSale (S): 30,000 @ $8.03EDGAR
2026-02-194Wijkstrom Joakim — SVP, Chief Marketing OfficerGrant/award (A): 125,000 @ $0EDGAR
2026-02-194Birznieks Gunther — SVP, Business DevelopmentGrant/award (A): 125,000 @ $0EDGAR
2026-02-194Williams Timothy — SVP & General CounselGrant/award (A): 125,000 @ $0EDGAR
2026-02-194Moran Kevin Patrick — SVP, CFO & TreasurerGrant/award (A): 125,000 @ $0EDGAR
2026-02-194Polymeropoulos Mihael Hristos — President and CEO, DirectorGrant/award (A): 525,000 @ $0EDGAR
2025-08-084Polymeropoulos Mihael Hristos — President and CEO, DirectorPurchase (P): 10,000 @ $4.15EDGAR
2025-06-164Mitchell Stephen Ray — DirectorSale (S): 7,000 @ $4.59EDGAR
2025-06-094Mitchell Stephen Ray — DirectorGrant/award (A): 59,225 @ $0EDGAR
2025-06-094Chrousos Phaedra — DirectorGrant/award (A): 59,225 @ $0EDGAR
2025-06-094Honore Tage — DirectorGrant/award (A): 59,225 @ $0EDGAR
2025-06-094Ward Anne Sempowski — DirectorGrant/award (A): 59,225 @ $0EDGAR
2025-06-094DUGAN RICHARD W — DirectorGrant/award (A): 59,225 @ $0EDGAR
2025-05-214Polymeropoulos Mihael Hristos — President and CEO, DirectorPurchase (P): 9,519 @ $4.40 · Purchase (P): 481 @ $4.39EDGAR
2025-05-194Polymeropoulos Mihael Hristos — President and CEO, DirectorPurchase (P): 20,000 @ $4.22EDGAR
2025-03-064Polymeropoulos Mihael Hristos — President and CEO, DirectorPurchase (P): 5,000 @ $5.02 · Purchase (P): 5,000 @ $5.01EDGAR
2025-03-054Polymeropoulos Mihael Hristos — President and CEO, DirectorPurchase (P): 5,000 @ $5.01 · Purchase (P): 5,000 @ $5.03EDGAR
2025-03-044Wijkstrom Joakim — SVP, Chief Marketing OfficerTax withholding (F): 15,520 @ $4.76EDGAR
2025-03-044Birznieks Gunther — SVP, Business DevelopmentTax withholding (F): 26,941 @ $4.76EDGAR
2025-03-044Polymeropoulos Mihael Hristos — President and CEO, DirectorTax withholding (F): 95,999 @ $4.76 · Purchase (P): 10,000 @ $4.71EDGAR
2025-03-044Moran Kevin Patrick — SVP, CFO & TreasurerTax withholding (F): 26,941 @ $4.76EDGAR
2025-03-044Williams Timothy — SVP & General CounselTax withholding (F): 26,941 @ $4.76EDGAR
2025-02-284Polymeropoulos Mihael Hristos — President and CEO, DirectorPurchase (P): 10,000 @ $4.76EDGAR
2025-02-274Polymeropoulos Mihael Hristos — President and CEO, DirectorPurchase (P): 10,000 @ $4.76EDGAR
2025-02-264Polymeropoulos Mihael Hristos — President and CEO, DirectorPurchase (P): 5,000 @ $4.75 · Purchase (P): 5,000 @ $4.78EDGAR
2025-02-254Polymeropoulos Mihael Hristos — President and CEO, DirectorPurchase (P): 10,000 @ $4.46EDGAR
2025-02-244Moran Kevin Patrick — SVP, CFO & TreasurerPurchase (P): 2,000 @ $4.39EDGAR
2025-02-204Wijkstrom Joakim — SVP, Chief Marketing OfficerGrant/award (A): 125,000 @ $0EDGAR
2025-02-204Polymeropoulos Mihael Hristos — President and CEO, DirectorGrant/award (A): 450,000 @ $0EDGAR
2025-02-204Moran Kevin Patrick — SVP, CFO & TreasurerGrant/award (A): 125,000 @ $0EDGAR
2025-02-204Birznieks Gunther — SVP, Business DevelopmentGrant/award (A): 125,000 @ $0EDGAR
2025-02-204Williams Timothy — SVP & General CounselGrant/award (A): 125,000 @ $0EDGAR
2024-11-184Mitchell Stephen Ray — DirectorSale (S): 5,000 @ $5.17EDGAR
2024-07-294Moran Kevin Patrick — SVP, CFO & TreasurerSale (S): 2,251 @ $5.92EDGAR
2024-05-244Chrousos Phaedra — DirectorGrant/award (A): 21,887 @ $0 · Grant/award (A): 40,202 (derivative) @ $0EDGAR

Recent 8-K events — Vanda Pharmaceuticals Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-208-K1.01 — Entry into a Material Definitive AgreementEDGAR
2026-10-288-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-058-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-228-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-028-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-03-108-K7.01 — Regulation FD DisclosureEDGAR
2026-02-238-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-198-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=VNDA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs